$366.05
Today
as of Jul 22, 16:45 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 2
● 23
▼ 0
Amgen (AMGN) Clears An Enbrel Overhang, Is The Stock Fully Priced?
Goldman Sachs Adjusts Price Target on Amgen to $427 From $425, Maintains Buy Rating
Amgen Earnings Preview: What to Expect
Overview
52-week range
$268
$391
80% of range
Avg surprise (last 2)
+16.1%
Avg reaction (last 1)
-2.5%
0% positive
Latest IV / EM
36%
EM ±2.1% · $365 · Jul 24
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $3.34 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $5.93 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $6.02 | $5.26 | +14.4% | — | — | earnings |
| Thu May 1, 2025 | Mar/2025 | $4.90 | $4.16 | +17.8% | — | -2.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $5.22 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $1.38 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.21 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $3.22 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $2.57 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | AMC | $5.60 | $6.02 | -7.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $2.74B | — | $3.08B | $3.01B | $2.97B | — | $3.31B | $3.24B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $2.67B | — | $2.53B | $2.66B | $1.18B | — | $2.05B | $1.91B |
| Net income | $1.82B | — | $3.22B | $1.43B | $1.73B | — | $2.83B | $746M |
| EPS (diluted) | $3.34 | — | $5.93 | $2.65 | $3.20 | — | $5.22 | $1.38 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $12.04B | $9.13B | $9.45B | $8.03B | $8.81B | $11.97B | $9.01B | $9.30B |
| Inventory | $6.19B | $6.22B | $6.35B | $6.58B | $6.73B | $7.00B | $7.36B | $8.00B |
| Total current assets | $31.48B | $29.06B | $27.89B | $26.73B | $26.93B | $29.03B | $26.77B | $27.21B |
| Total assets | $92.50B | $90.59B | $90.14B | $87.90B | $89.37B | $91.84B | $90.88B | $90.91B |
| Long-term debt | $51.89B | $50.01B | $52.43B | $53.76B | $54.01B | $56.55B | $56.85B | $57.12B |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $9.19B | $8.66B | $9.62B | $7.43B | $6.21B | $5.88B | $7.53B | $5.92B |